🟢 Quantum BioPharma is trading 7.43% up in pre-market after a 7.18% prior-session decline

Quantum BioPharma is trading at $3.47 (+7.43%) in pre-market, rebounding after a 7.18% decline on August 13.

• No fresh company-specific announcement was identified for August 14, 2026.
• The latest major catalyst was FDA clearance for Lucid-MS Phase 2 on August 10, not a new event today.
• Broader markets are only modestly higher and do not clearly explain the move.